PFO
AIFF

Pathstone Family Office’s Firefly Neuroscience AIFF Stock Holding History

Pathstone Family Office’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,741
Closed -$25.1K – 1695
2023
Q2 		$25.1K Sell
2,741
-549
-17% -$6.22K ﹤0.01% 1226
2023
Q1 		$28.6K Buy
+3,290
New +$64.8K ﹤0.01% 1172

Other funds holding AIFF

LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Pathstone Family Office's AIFF Position: Q3 2023 in Review

Pathstone Family Office sold out of Firefly Neuroscience (AIFF) in Q3 2023, closing a stake of 2,741 shares — an estimated $25.1K sold.

Pathstone Family Office first reported a position in AIFF in Q1 2023 and held it in 2 quarters. The position peaked at $28.6K in Q1 2023. 12 funds tracked by Wall St. Rank hold AIFF as of Q3 2023.

  • Pathstone Family Office reported no remaining Firefly Neuroscience position as of Q3 2023 after selling out during the quarter.
  • Pathstone Family Office sold 2,741 Firefly Neuroscience shares in Q3 2023, an estimated $25.1K.
  • Pathstone Family Office first reported a position in Firefly Neuroscience in Q1 2023 and held it in 2 quarters.
  • Pathstone Family Office's Firefly Neuroscience position peaked at $28.6K in Q1 2023.
  • 12 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.